Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight-Reference-Cited by-同舟云学术

Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight

Published:2019-05-14 Issue:20 Volume:139 Page:2292-2300
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Hohnloser Stefan H.¹,Fudim Marat²,Alexander John H.²,Wojdyla Daniel M.²,Ezekowitz Justin A.³,Hanna Michael⁴,Atar Dan⁵,Hijazi Ziad⁶,Bahit M. Cecilia⁷,Al-Khatib Sana M.²,Lopez-Sendon Jose Luis⁸,Wallentin Lars⁶,Granger Christopher B.²,Lopes Renato D.²

Affiliation:

1. Johann Wolfgang Goethe University, Frankfurt, Germany (S.G.G.).

2. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (M.F., J.H.A., D.M.W., S.M.A.-K., C.B.G., R.D.L.).

3. University of Alberta, Alberta, Canada (J.A.E.).

4. Bristol-Myers Squibb, Princeton, NJ (M.H.).

5. University of Oslo, Norway (D.A.).

6. Uppsala Clinical Research Center, Uppsala University, Sweden (Z.H., L.W.).

7. Fundación INECO Rosario, Department of Cardiology, INECO Neurociencias Orono, Santa Fe, Argentina (M.C.B.).

8. Hospital Universitario La Paz, Madrid, Spain (J.L.L.-S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Prevalence of Childhood and Adult Obesity in the United States, 2011-2012

2. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis

3. Updated European Heart Rhythm Association practical guide on the use of non–vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary.;Heidbuchel H;Eur Heart J,2017

4. Apixaban versus Warfarin in Patients with Atrial Fibrillation

5. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Journal of Preventive Cardiology;2024-08-30

2. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Heart Journal;2024-08-30

3. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation;Journal of Thrombosis and Thrombolysis;2024-08-14

4. Mechanical Aortic Valve Thrombosis During Anticoagulation Using Oral Rivaroxaban: A Case Report;Cureus;2024-07-20

5. Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-27